stars 1 stars 2 stars 3

Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com.

View Top Employees from Synairgen Research Ltd

Synairgen Research Ltd Questions

The Synairgen Research Ltd annual revenue was $4 million in 2024.

Richard Hennings is the Chief Commercial Officer of Synairgen Research Ltd.

24 people are employed at Synairgen Research Ltd.

The NAICS codes for Synairgen Research Ltd are [5417, 54171, 54, 32541, 32, 541714, 541, 325, 325413, 3254].

The SIC codes for Synairgen Research Ltd are [87, 873].

Top Synairgen Research Ltd Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users